Time to end secret data laboratories—starting with the CDC
The American people are waking up to the fact that too many public health leaders have not always been straight with them. Despite housing treasure…
Thought Leader: Marty Makary
Odd Lots: What is Happening with Biden’s CHIPS Act?
In August of last year, the White House signed the CHIPS and Science Act of 2022, a bipartisan effort to bring more advanced semiconductor manufacturing onto US shores. Of course, it already has plenty of critics. There are concerns that the bill is being larded up with red tape, or non-core progressive priorities, that will undermine the bill. On this episode, we speak to two leaders playing key roles in the act’s implementation. Mike Schmidt, director of the CHIPS Program Office, and Todd Fisher, the program’s chief investment officer, join us to talk about the act’s goals, what’s been achieved so far, and why they believe it can succeed.
Relevant posts
Scott Gottlieb: How well can AI chatbots mimic doctors in a treatment setting?
This is an Op-ed by WWSG exclusive thought leader, Dr. Scott Gottlieb. Many consumers and medical providers are turning to chatbots, powered by large language…
Thought Leader: Scott Gottlieb
Sara Fischer: The AI-generated disinformation dystopia that wasn’t
This piece is by WWSG exclusive thought leader, Sara Fischer. Amid the craziest news cycle in recent memory, AI-generated deepfakes have yet to become the huge truth…
Thought Leader: Sara Fischer
